and create the first barrier of the host's defense. Following stimulation, neutrophils synthesize and release important inflammatory mediators, including cytokines, chemokines, leukotrienes, and prostaglandins, which contribute to phagocytosis, bacterial killing, oxidative bursts, and degranulation [5, 6] . In this way, neutrophils play a pivotal role in the occurrence of organ dysfunction related to serious infection. Nontoxic substances that control neu-
trophil-mediated inflammatory-immune responses could
provide new methods for the treatment of sepsis.
Flecainide acetate, a potent sodium channel blocker, exerts electrophysiological effects to control supraventricular tachycardia and has been widely used in clinical settings.
In addition to its electrophysiological effects, flecainide acetate affects autoimmune neutropenia [7] and the inhibition of human tumor necrosis factor-alpha (TNF-α) [8] .
However, the ability of this sodium channel blocker to directly participate in neutrophil activation by lipopolysaccharide (LPS) has not been studied. In this study, we evaluated whether flecainide acetate decreases the activa- 
MaterIals and Methods

Animals
Male Sprague-Dawley rats, 8-12 weeks of age, were purchased from Damul Science (Daejeon, Korea). The rats were kept on a 12-hour light/dark cycle with free access to food and water. All experiments were conducted in accordance with Chonnam National University's Institutional Animal Care and Use Committee.
Materials
Escherichia coli O11:B4 endotoxin (LPS) was purchased 
Isolation of Neutrophils
For human neutrophil isolation, peripheral blood was obtained from healthy volunteers under a protocol approved by Institutional Review Board of Chonnam National University Hospital (IRB No. CNUH-2012-048).
Neutrophils were isolated using plasma-Percoll gradients after dextran sedimentation of erythrocytes as described previously [9] . The neutrophil purity, as determined using Wright-stained cytospin preparations, was greater than 97%. The cell viability, as determined using trypan blue exclusion, was consistently greater than 98%.
Cytokine Enzyme-Linked Immunosorbent Assay
Immunoreactive TNF-α, IL-6 and IL-8 were quantified using commercially available enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions as described previously [10] .
Western Blot Analysis
Western blots to detect the levels of phosphorylated and total p38, ERK, and JNK were performed essentially as previously described [10, 11] (1:1000 dilution) in 1% BSA, followed by an anti-rabbit or anti-rat immunoglobulin G horseradish peroxidase-coupled secondary antibody (1:2000 dilution) in 5% nonfat dry milk. After washing five times, the bands were detected using electrochemiluminescence Western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The membranes were then stripped using stripping buffer (63 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate, 100 mM 2-ME; Bio-Rad, Hercules, CA, USA) and reprobed with antibodies specific to total ERK, JNK, and p38. Densitometry was performed using a chemiluminescence system and the included analysis software (Bio-Rad) to determine the ratio between the phosphorylated and total kinases.
Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assays were performed as previously described [10, 12] . To obtain nuclear extracts from the neutrophils, the cells were resuspended in buffer.
A containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, and 0.5 mM dithiothreitol, and the samples were incubated on ice for 20 minutes. After the cytoplasm was removed from the nuclei using 15 passages through a 25-gauge needle, the nuclei were collected using centrifugation at 600 ×g for 6 minutes at 4°C. The pellets were suspended in buffer C containing 20 mM HEPES, 1.5 mM 
In vivo Sepsis Model
Sepsis was induced via intraperitoneal (IP) administration of 25 mg/kg of O4:B111 E. coli endotoxin (LPS) into rats.
Animals were randomly assigned to one of five groups: 
Statistical Analysis
The data are presented as the mean ± standard error for each experimental group. One-way analysis of variance and the Tukey-Kramer multiple comparisons test (for multiple groups) or the Student t-test (for comparisons between two groups) was used. Null hypotheses of no difference were rejected if the P-values were less than 0.05. 
results
The Effects of
The Effects of Flecainide Acetate on MAPK Pathway Activation in LPS-Stimulated Neutrophils
Western blot analyses demonstrated notably higher /ml) from human blood were incubated for 4 hours with or without flecainide acetate (1, 10, or 100 μM) and with or without LPS (100 ng/ml) with the control group (CON) receiving no treatment. The protein levels were obtained using enzyme-linked immunosorbent assays. A representative experiment, in which each condition was examined in triplicate, is shown. Two additional experiments provided similar results. The data are presented as mean ± standard error for each experimental group. IL: interleukin; LPS: lipopolysaccharide; TNF-α: tumor necrosis factor-alpha. Treatment with a combination of LPS and flecainide acetate (100 µM) had no effect on the JNK or p38 pathways.
However, the combination significantly reduced activation of the ERK 1/2 pathway compared with the LPS group (Figure 2 ).
The Effects of Flecainide Acetate on the Activation of NF-κB in LPS-Stimulated Neutrophils
To assess the effects of flecainide acetate on transcriptional regulation in LPS-stimulated neutrophils, we examined the nuclear levels of NF-κB in neutrophils cul- 
The Effects of Flecainide Acetate on Mortality in an LPS-Induced Rat Sepsis Model
To determine the effects of flecainide acetate in a rat sepsis model, rats were intraperitoneally injected with 25 mg/kg of LPS, and mortality was evaluated after 24 hours. Mortality was over 40% in the S-E (positive con- 
dIscussIon
The main result of this study is that flecainide acetate has potential anti-inflammatory activities, including decreasing the activation of NF-κB and proinflammatory cytokines, in LPS-stimulated neutrophils in vitro. In additional in vivo studies, rats treated with flecainide acetate were protected from endotoxemia-induced sepsis as determined by mortality rates.
Binding sites for NF-κB are present in the promoter regions of the TNF-α, IL-6 and IL-8 genes, and NF-κB plays a pivotal role in the transcriptional control of each of these cytokines [10] . Additionally, p38 and ERK are involved in enhancing the activation of NF-κB and NF-κB-dependent genes in LPS-stimulated neutrophils [10, 13] .
Proinflammatory cytokines, such as TNF-α, IL-6 and IL-8, are major inflammatory mediators [14] . LPSstimulated neutrophils up-regulate many kinases associated with the activation of proinflammatory cytokines.
Among them, signaling pathways that bring about the activation of MAPKs (p38 and ERK 1/2) are especially important because the attenuation of MAPK-activation remarkably inhibits the activation of mediator cytokines that is induced by LPS [10, 13, 15] . Conversely, some studies also suggest that JNK, one of the members of the MAPK family, is activated in the proinflammatory events induced neutrophils [16, 17] . Under these signaling pathways, neutrophils increase the release of oxygen radicals, proteases, leukotrienes, and proinflammatory cytokines (TNF-α, IL-1β and IL-8) [18] [19] [20] [21] . Blocking the activation of these signaling pathways is a key strategy in the treatment of sepsis. In this study, we demonstrated the ability of flecainide acetate to attenuate neutrophil action in vitro and improve survival rates in an LPS-induced rat sepsis model. These effects suggest that flecainide acetate plays a major role in the regulation of neutrophil-mediated inflammatory responses.
